TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive “The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts” October 28, 1994
TCL Archive Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines January 13, 2012
TCL Archive FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer September 27, 2013
